{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,29]],"date-time":"2026-10-29T23:59:09Z","timestamp":1793318349724,"version":"4.5.0"},"reference-count":28,"publisher":"Elsevier BV","issue":"10","license":[{"start":{"date-parts":[[2020,10,1]],"date-time":"2020-10-01T00:00:00Z","timestamp":1601510400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,10,1]],"date-time":"2020-10-01T00:00:00Z","timestamp":1601510400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004329","name":"Javna Agencija za Raziskovalno Dejavnost RS","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100004329","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","mayoclinicproceedings.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Mayo Clinic Proceedings"],"published-print":{"date-parts":[[2020,10]]},"DOI":"10.1016\/j.mayocp.2020.02.031","type":"journal-article","created":{"date-parts":[[2020,10,1]],"date-time":"2020-10-01T08:11:05Z","timestamp":1601539865000},"page":"2125-2133","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":8,"title":["Larger End-Diastolic Volume Associates With Response to Cell Therapy in Patients With Nonischemic Dilated Cardiomyopathy"],"prefix":"10.1016","volume":"95","author":[{"given":"Sabina","family":"Frljak","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gregor","family":"Poglajen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gregor","family":"Zemljic","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andraz","family":"Cerar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Francois","family":"Haddad","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andre","family":"Terzic","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7383-1281","authenticated-orcid":false,"given":"Bojan","family":"Vrtovec","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"10","key":"10.1016\/j.mayocp.2020.02.031_bib1","doi-asserted-by":"crossref","first-page":"1158","DOI":"10.1016\/j.healun.2016.08.017","article-title":"The Registry of the International Society for Heart and Lung Transplantation: Thirty-third Adult Heart Transplantation Report-2016; Focus Theme: Primary Diagnostic Indications for Transplant","volume":"35","author":"Lund","year":"2016","journal-title":"J\u00a0Heart Lung Transplant"},{"issue":"44","key":"10.1016\/j.mayocp.2020.02.031_bib2","doi-asserted-by":"crossref","first-page":"3061","DOI":"10.1093\/eurheartj\/ehv390","article-title":"Randomized trial of combination cytokine and adult autologous bone marrow progenitor cell administration in patients with non-ischaemic dilated cardiomyopathy: the REGENERATE- DCM clinical trial","volume":"36","author":"Hamshere","year":"2015","journal-title":"Eur Heart J"},{"issue":"11 suppl 1","key":"10.1016\/j.mayocp.2020.02.031_bib3","first-page":"S42","article-title":"Comparison of transendocardial and intracoronary CD34+ cell transplantation in patients with nonischemic dilated cardiomyopathy","volume":"128","author":"Vrtovec","year":"2013","journal-title":"Circulation"},{"issue":"1","key":"10.1016\/j.mayocp.2020.02.031_bib4","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1161\/CIRCRESAHA.112.276519","article-title":"Effects of intracoronary CD34+ stem cell transplantation in nonischemic dilated cardiomyopathy patients: 5-year follow-up","volume":"112","author":"Vrtovec","year":"2013","journal-title":"Circ Res"},{"issue":"1","key":"10.1016\/j.mayocp.2020.02.031_bib5","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1161\/CIRCRESAHA.117.312385","article-title":"Cell Therapy for Nonischemic cardiomyopathy: current status and future perspectives","volume":"122","author":"Vrtovec","year":"2018","journal-title":"Circ Res"},{"issue":"13","key":"10.1016\/j.mayocp.2020.02.031_bib6","doi-asserted-by":"crossref","first-page":"1033","DOI":"10.1093\/eurheartj\/ehz095","article-title":"Regeneration for all: an odyssey in biotherapy","volume":"40","author":"Behfar","year":"2019","journal-title":"Eur Heart J"},{"issue":"11","key":"10.1016\/j.mayocp.2020.02.031_bib7","doi-asserted-by":"crossref","first-page":"659","DOI":"10.1038\/s41569-018-0013-0","article-title":"Cell therapy trials for heart regeneration - lessons learned and future directions","volume":"15","author":"Menasch\u00e9","year":"2018","journal-title":"Nat Rev Cardiol"},{"issue":"6","key":"10.1016\/j.mayocp.2020.02.031_bib8","doi-asserted-by":"crossref","first-page":"558","DOI":"10.1161\/CIRCRESAHA.114.304792","article-title":"Adult bone marrow cell therapy for ischemic heart disease: evidence and insights from randomized controlled trials","volume":"117","author":"Afzal","year":"2015","journal-title":"Circ Res"},{"issue":"9","key":"10.1016\/j.mayocp.2020.02.031_bib9","first-page":"648","article-title":"Cardiopoietic cell therapy for advanced ischaemic heart failure: results at 39 weeks of the prospective, randomized, double blind, sham-controlled CHART-1 clinical trial","volume":"38","author":"Bartunek","year":"2017","journal-title":"Eur Heart J"},{"issue":"11","key":"10.1016\/j.mayocp.2020.02.031_bib10","doi-asserted-by":"crossref","first-page":"1520","DOI":"10.1002\/ejhf.898","article-title":"Benefit of cardiopoietic mesenchymal stem cell therapy on left ventricular remodelling: results from the Congestive Heart Failure Cardiopoietic Regenerative Therapy (CHART-1) study","volume":"19","author":"Teerlink","year":"2017","journal-title":"Eur J Heart Fail"},{"issue":"10","key":"10.1016\/j.mayocp.2020.02.031_bib11","doi-asserted-by":"crossref","first-page":"1344","DOI":"10.1161\/CIRCRESAHA.118.312753","article-title":"Clinical experience with regenerative therapy in heart failure: advancing care with cardiopoietic stem cell interventions","volume":"122","author":"Bartunek","year":"2018","journal-title":"Circ Res"},{"issue":"2","key":"10.1016\/j.mayocp.2020.02.031_bib12","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1016\/j.cardfail.2016.08.002","article-title":"Electroanatomic properties of the myocardium predict response to CD34+ cell therapy in patients with ischemic and nonischemic heart failure","volume":"23","author":"Zemljic","year":"2017","journal-title":"J\u00a0Card Fail"},{"issue":"6","key":"10.1016\/j.mayocp.2020.02.031_bib13","doi-asserted-by":"crossref","first-page":"446","DOI":"10.1007\/s00059-007-3045-5","article-title":"The classification concept of the ESC Working Group on myocardial and pericardial diseases for dilated cardiomyopathy","volume":"32","author":"Kaski","year":"2007","journal-title":"Herz"},{"issue":"8","key":"10.1016\/j.mayocp.2020.02.031_bib14","doi-asserted-by":"crossref","first-page":"778","DOI":"10.1093\/eurheartj\/ehi162","article-title":"Six minute corridor walk test as an outcome measure for the assessment of treatment in randomized, blinded intervention trials of chronic heart failure: a systematic review","volume":"26","author":"Olsson","year":"2005","journal-title":"Eur Heart J"},{"issue":"3","key":"10.1016\/j.mayocp.2020.02.031_bib15","doi-asserted-by":"crossref","first-page":"609","DOI":"10.1111\/j.1365-2141.1994.tb08321.x","article-title":"G-CSF\u2013mobilized peripheral blood progenitor cells for allogeneic transplantation: safety, kinetics of mobilization, and composition of the graft","volume":"87","author":"Dreger","year":"1994","journal-title":"Br J Haematol"},{"issue":"21","key":"10.1016\/j.mayocp.2020.02.031_bib16","doi-asserted-by":"crossref","first-page":"2194","DOI":"10.1016\/j.jacc.2012.08.977","article-title":"New unipolar electrogram criteria to identify irreversibility of nonischemic left ventricular cardiomyopathy","volume":"60","author":"Campos","year":"2012","journal-title":"J\u00a0Am Coll Cardiol"},{"issue":"5","key":"10.1016\/j.mayocp.2020.02.031_bib17","doi-asserted-by":"crossref","first-page":"392","DOI":"10.1016\/j.jacc.2010.05.011","article-title":"Quantitative evaluation of drug or device effects on ventricular remodeling as predictors of therapeutic effects on mortality in patients with heart failure and reduced ejection fraction: a meta-analytic approach","volume":"56","author":"Kramer","year":"2010","journal-title":"J\u00a0Am Coll Cardiol"},{"issue":"2","key":"10.1016\/j.mayocp.2020.02.031_bib18","doi-asserted-by":"crossref","first-page":"228","DOI":"10.1002\/ejhf.1103","article-title":"Evolving concepts in dilated cardiomyopathy","volume":"20","author":"Merlo","year":"2018","journal-title":"Eur J Heart Fail"},{"key":"10.1016\/j.mayocp.2020.02.031_bib19","first-page":"52","article-title":"Reverse remodeling in dilated cardiomyopathy: Insights and future perspectives","volume":"18","author":"Merlo","year":"2018","journal-title":"Int J Cardiol Heart Vasc"},{"issue":"11","key":"10.1016\/j.mayocp.2020.02.031_bib20","doi-asserted-by":"crossref","first-page":"1112","DOI":"10.1016\/j.jacc.2011.05.033","article-title":"Clinical and demographic predictors of outcomes in recent onset dilated cardiomyopathy: results of the IMAC (Intervention in Myocarditis and Acute Cardiomyopathy)-2 study","volume":"58","author":"McNamara","year":"2011","journal-title":"J\u00a0Am Coll Cardiol"},{"issue":"3","key":"10.1016\/j.mayocp.2020.02.031_bib21","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1161\/CIRCRESAHA.117.312170","article-title":"Effects of repetitive transendocardial CD34(+) cell transplantation in patients with nonischemic dilated cardiomyopathy","volume":"123","author":"Vrtovec","year":"2018","journal-title":"Circ Res"},{"issue":"8","key":"10.1016\/j.mayocp.2020.02.031_bib22","doi-asserted-by":"crossref","first-page":"1292","DOI":"10.1161\/CIRCRESAHA.114.302854","article-title":"Does transendocardial injection of mesenchymal stem cells improve myocardial function locally or globally?: An analysis from the Percutaneous Stem Cell Injection Delivery Effects on Neomyogenesis (POSEIDON) randomized trial","volume":"114","author":"Suncion","year":"2014","journal-title":"Circ Res"},{"issue":"25","key":"10.1016\/j.mayocp.2020.02.031_bib23","doi-asserted-by":"crossref","first-page":"2792","DOI":"10.1016\/j.jacc.2014.10.016","article-title":"Defining \"severe\" secondary mitral regurgitation: emphasizing an integrated approach","volume":"64","author":"Grayburn","year":"2014","journal-title":"J\u00a0Am Coll Cardiol"},{"issue":"9","key":"10.1016\/j.mayocp.2020.02.031_bib24","first-page":"652","article-title":"Evolution of functional mitral regurgitation and prognosis in medically managed heart failure patients with reduced ejection fraction","volume":"5","author":"Nasser","year":"2017","journal-title":"J\u00a0Am Coll Cardiol HF"},{"issue":"8","key":"10.1016\/j.mayocp.2020.02.031_bib25","doi-asserted-by":"crossref","first-page":"1137","DOI":"10.1016\/j.amjcard.2015.01.549","article-title":"Early improvement of functional mitral regurgitation in patients with idiopathic dilated cardiomyopathy","volume":"115","author":"Stolfo","year":"2015","journal-title":"Am J Cardiol"},{"issue":"8","key":"10.1016\/j.mayocp.2020.02.031_bib26","doi-asserted-by":"crossref","first-page":"517","DOI":"10.1007\/s11886-014-0517-0","article-title":"Ischemic and functional mitral regurgitation in heart failure: natural history and treatment","volume":"16","author":"Benjamin","year":"2014","journal-title":"Curr Cardiol Rep"},{"issue":"24","key":"10.1016\/j.mayocp.2020.02.031_bib27","doi-asserted-by":"crossref","first-page":"2307","DOI":"10.1056\/NEJMoa1806640","article-title":"Transcatheter mitral-valve repair in patients with heart failure","volume":"379","author":"Stone","year":"2018","journal-title":"N\u00a0Engl J Med"},{"issue":"24","key":"10.1016\/j.mayocp.2020.02.031_bib28","doi-asserted-by":"crossref","first-page":"2297","DOI":"10.1056\/NEJMoa1805374","article-title":"Percutaneous repair or medical treatment for secondary mitral regurgitation","volume":"379","author":"Obadia","year":"2018","journal-title":"N\u00a0Engl J Med"}],"container-title":["Mayo Clinic Proceedings"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0025619620302159?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0025619620302159?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,21]],"date-time":"2025-09-21T01:33:06Z","timestamp":1758418386000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0025619620302159"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,10]]},"references-count":28,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2020,10]]}},"alternative-id":["S0025619620302159"],"URL":"https:\/\/doi.org\/10.1016\/j.mayocp.2020.02.031","relation":{},"ISSN":["0025-6196"],"issn-type":[{"value":"0025-6196","type":"print"}],"subject":[],"published":{"date-parts":[[2020,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Larger End-Diastolic Volume Associates With Response to Cell Therapy in Patients With Nonischemic Dilated Cardiomyopathy","name":"articletitle","label":"Article Title"},{"value":"Mayo Clinic Proceedings","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.mayocp.2020.02.031","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 Mayo Foundation for Medical Education and Research","name":"copyright","label":"Copyright"}]}}